radical prostatectomy

Also found in: Dictionary, Thesaurus, Acronyms, Encyclopedia.


surgical removal of the prostate.
radical prostatectomy removal of the prostate with its capsule, seminal vesicles, ductus deferens, some pelvic fasciae, and sometimes pelvic lymph nodes; performed via either the retropubic or the perineal route.

radical prostatectomy

 The complete surgical removal of the prostate–a widely used method for treating prostate CA Types Retropubic prostatectomy, perineal prostatectomy

Radical prostatectomy

Surgical removal of the entire prostate, a common method of treating prostate cancer.
Mentioned in: Prostate Cancer
References in periodicals archive ?
Management of localized prostate cancer by retropubic radical prostatectomy in patients after renal transplantation.
To our knowledge, this is the first work focusing on comparing the morphologic findings at radical prostatectomy between GS 7 cases with and without pelvic [LN.
Addition of robotic surgery to an established laparoscopic radical prostatectomy program: Initial impact of positive surgical margins [Abstract 351].
The value of serum prostate specific antigen determinations before and after radical prostatectomy.
Radical prostatectomy, on the other hand, is a major operation followed by weeks of recuperation and pain, not to mention occasional incontinence and an estimated 30 percent risk of impotence.
Surgeons who are not well-trained in radical prostatectomy must be aware that they might experience a longer and more painful learning experience.
Perhaps what is more important for the average patient treated with radical prostatectomy at our institution is the high negative predictive value of this genomic test.
Clinicians use various tools, such as Partin tables or Kattan nomograms, to predict outcomes, including the pathologic stage or prognosis following radical prostatectomy or radiotherapy.
The yet-to-be-published main results of PIVOT offer a different take on the value of radical prostatectomy from the recently published results of the Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4), a pre-PSA-era trial that showed a significant overall benefit to surgery, even in men with tumors deemed to be low risk.
Washington, May 16 (ANI): Mayo clinic researchers have found that 80 percent of patients diagnosed with cancer that has spread beyond the prostate, known as cT3 prostate cancer patients, has 20 years survival rate if treated with radical prostatectomy, or surgery to remove the prostate gland.